|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 142.49 ZAR | +5.55% |
|
+8.18% | +22.01% |
| 11:33am | South Africa seeks local production of Gilead's HIV prevention drug | RE |
| 04/03 | Drugmaker Aspen targets Mounjaro approval in sub-Saharan Africa this year | RE |
| Capitalization | 6.33TCr 387.11Cr 332.88Cr 302.08Cr 289.71Cr 529.05Cr 36TCr 548.11Cr 3.55TCr 1.42TCr 17TCr 1.45TCr 1.42TCr 61TCr | P/E ratio 2026 * |
12.3x | P/E ratio 2027 * | 11.3x |
|---|---|---|---|---|---|
| Enterprise value | 9.16TCr 560.56Cr 482.03Cr 437.42Cr 419.51Cr 766.09Cr 52TCr 793.7Cr 5.14TCr 2.06TCr 25TCr 2.1TCr 2.06TCr 88TCr | EV / Sales 2026 * |
2.08x | EV / Sales 2027 * | 1.98x |
| Free-Float |
61.37% | Yield 2026 * |
1.69% | Yield 2027 * | 1.93% |
Last Transcript: Aspen Pharmacare Holdings Limited
| 1 day | +5.55% | ||
| 1 week | +8.18% | ||
| Current month | +5.23% | ||
| 1 month | +29.54% | ||
| 3 months | +52.28% | ||
| 6 months | +38.61% | ||
| Current year | +22.01% |
| 1 week | 130.11 |  | 143.61 |
| 1 month | 106.46 | | 143.61 |
| Current year | 104.38 | | 143.61 |
| 1 year | 90.7 | | 185.95 |
| 3 years | 90.7 | | 252.96 |
| 5 years | 90.7 | | 281.67 |
| 10 years | 64.07 | | 388.49 |
| Manager | Title | Age | Since |
|---|---|---|---|
Stephen Saad
CEO | Chief Executive Officer | 62 | 01/01/1997 |
Sean Capazorio
DFI | Director of Finance/CFO | 61 | 01/01/2009 |
| Chief Operating Officer | 63 | 01/01/1999 |
| Director | Title | Age | Since |
|---|---|---|---|
Stephen Saad
BRD | Director/Board Member | 62 | 01/01/1999 |
| Director/Board Member | 65 | 01/01/1999 | |
Kuseni Dlamini
CHM | Chairman | 58 | 07/12/2015 |
| Change | 5d. change | 1-year change | 3-years change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +5.55% | +8.18% | -19.26% | -17.40% | 387.11Cr | |
| +1.91% | -0.10% | +12.74% | +84.82% | 4.56TCr | |
| +0.84% | -2.16% | +37.10% | +156.82% | 3.39TCr | |
| +0.81% | -2.50% | -6.74% | +50.31% | 1.15TCr | |
| -14.46% | +10.63% | +255.18% | +1,031.58% | 1.03TCr | |
| +1.38% | -3.08% | +2.50% | +91.03% | 978.99Cr | |
| -2.48% | -6.71% | +57.59% | +32.86% | 754.93Cr | |
| +6.02% | -5.37% | +37.95% | +114.02% | 811.3Cr | |
| +2.36% | -4.97% | +53.09% | -11.22% | 728.88Cr | |
| +2.02% | -1.96% | +50.04% | +394.50% | 624.4Cr | |
| Average | +0.41% | -1.03% | +48.02% | +192.73% | 1.44TCr | |
| Weighted average by Cap. | +0.50% | -1.31% | +40.04% | +171.56% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 4.41TCr 269.63Cr 231.86Cr 210.4Cr 201.79Cr 368.49Cr 25TCr 381.77Cr 2.47TCr 989.66Cr 12TCr 1.01TCr 990.36Cr 42TCr | 4.46TCr 272.99Cr 234.75Cr 213.03Cr 204.3Cr 373.09Cr 25TCr 386.53Cr 2.5TCr 1TCr 12TCr 1.02TCr 1TCr 43TCr |
| Net income | 519.16Cr 32Cr 27Cr 25Cr 24Cr 43Cr 2.93TCr 45Cr 291.19Cr 116.59Cr 1.4TCr 119.24Cr 116.67Cr 4.99TCr | 523.63Cr 32Cr 28Cr 25Cr 24Cr 44Cr 2.95TCr 45Cr 293.7Cr 117.59Cr 1.41TCr 120.26Cr 117.68Cr 5.03TCr |
| Net Debt | 2.83TCr 173.45Cr 149.15Cr 135.35Cr 129.8Cr 237.04Cr 16TCr 245.58Cr 1.59TCr 636.62Cr 7.63TCr 651.06Cr 637.07Cr 27TCr | 2.53TCr 154.54Cr 132.89Cr 120.59Cr 115.65Cr 211.2Cr 14TCr 218.81Cr 1.42TCr 567.22Cr 6.79TCr 580.1Cr 567.62Cr 24TCr |
| Date | Price | Change | Volume |
|---|---|---|---|
| 04/26/04 | 142.49 R | +5.55% | 32,27,554 |
| 03/26/03 | 135.00 R | +0.45% | 18,21,284 |
| 02/26/02 | 134.40 R | -0.75% | 16,19,803 |
| 27/26/27 | 135.41 R | -0.08% | 15,22,928 |
| 26/26/26 | 135.52 R | +2.89% | 13,93,336 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Global Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Global Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite), and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be performed. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of the rankings based on the following ratings: Capital Efficiency (Composite), Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully review the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Annual profits - Rate of surprise
- Stock Market
- Equities
- APN Stock
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition